Venture-Backed Startups
101,692 companies with verified investor relationships.
0 investors
BioSeek builds an AI platform for drug discovery that unifies fragmented biological sources—literature, patents, clinical, and chemistry data—into a connected knowledge graph, with specialist agents that reason across it from disease biology to safety-screened molecules. The software is deployed inside a customer's own infrastructure so proprietary data and tools join the private graph without leaving their environment, targeting enterprise pharma and biotech research teams.
1 investor
Sens.bio manufactures a portable device for on-site detection of mycotoxins in grains and animal feed using a test cartridge and mobile app data analysis. The device serves agronomic researchers, farms, and grain storage operators to assess crop and feed contamination quickly without laboratory analysis.
1 investor
BioSens8 develops a platform that identifies microbes to engineer biosensors for quantitative, real-time, and continuous monitoring. The company is expanding its biosensor technology beyond glucose monitoring.
1 investor
Biosense Technologies develops user-friendly medical devices for basic screening tests, aimed at reducing the load on primary healthcare services and enabling users to screen and manage conditions in real time. Its focus areas include diseases such as diabetes, heart disease, and cancer.
1 investor
0 investors
0 investors
0 investors
Biosimo produces bio-based platform chemicals — with bio-acetic acid as its flagship, plus acetaldehyde, ethyl acetate, and bio-VAM — by converting bioethanol using a proprietary heterogeneous catalyst in a single continuous fixed-bed reactor step. The company, an ETH Zurich spin-off, sells to industries including agriculture, automotive, construction, home care, and cosmetics, aiming to compete at fossil-fuel economics.
2 investors
0 investors
0 investors
0 investors
Biosortia is a drug discovery company whose Industrial-Scale Microbiome Mining (ISMM) platform extracts community-derived small molecules from the microbiome at kilogram-to-ton scale, using an AI tool (BiosortAI) to prioritize evolutionarily shaped compounds. Its lead program targets obesity and metabolic disease, with expansion into IBD, gut-brain neuromodulation, oncology, pain, and anti-infectives.
1 investor
Bios Partners is a venture capital firm focused on life sciences and biotech investments, providing diligence and portfolio support for clinical-stage and precision medicine companies. The firm combines deep expertise in drug development, pharmaceutical R&D, and equity research for healthcare institutions.
1 investor
biospatial operates an EMS data platform that combines electronic patient care reports (ePCR) from a network of emergency medical services providers with other healthcare data, using AI to detect trends, benchmarks, and anomalies. It serves EMS agencies, federal government, hospitals, and behavioral health organizations with analytics for biosurveillance, overdose tracking, and disaster response.
4 investors
Biospectal develops OptiBP, a smartphone app that measures and tracks blood pressure using a fingertip on the phone's camera, allowing users to record BP history and share it with doctors. The app is CE-MDR EU Class IIa certified and targets people managing hypertension and heart health.
1 investor
BioSpeedia is a biotechnology company that develops and produces rapid lateral-flow diagnostic tests for infectious diseases, including tests for bacterial meningitis and SARS-CoV-2. A spin-off from the Institut Pasteur, it distributes its diagnostic products worldwide through affiliated entities.
1 investor
Biosphere develops a modern, UV-enabled bioreactor designed to lower the capital intensity of biomanufacturing, replacing legacy steam-based bioreactor designs. Its technology targets industrial biology applications such as therapeutics, enzymes, proteins, bioplastics, fertilizers, and jet fuel.
2 investors
Biospring is an investment firm that partners with technology-enabled, EBITDA-positive pharma services businesses focused on manufacturing and clinical trial services. Its portfolio companies produce and support the supply chain for complex medicines such as biologics, cell therapies, and peptides, and modernize clinical trial site operations, patient recruitment, and related technology for the life sciences industry.
1 investor
BioSqueeze develops well integrity solutions for the oil and gas industry, using biomineralization technology to seal cement gaps and leaks in wells. The company offers multiple sealing products (MicroSeal, MacroSeal, NanoSeal) and diagnostic services for well remediation and decommissioning.
2 investors
Cardiovascular device company developing HAART aortic valve repair technologies as an alternative to valve replacement. Assets acquired by Corcym in 2023.
1 investor
BioStack provides a platform for bioinformatics and experimental science that integrates biological insights with computational technology. The platform serves researchers and scientists working in modern biology and life sciences research.
3 investors
Biostate AI is a biotech company that develops AI-driven solutions for the life sciences and medical research sectors. The company operates multiple international subsidiaries and partnerships focused on advancing genomics and health diagnostics.
3 investors
0 investors